SCHEMBL6570948

SCHEMBL6570948

C[C](C)C(C)CCCc1cccc(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.49
HTR3B O95264 1/20 0.49
HTR3A P46098 1/20 0.49
HTR3D Q70Z44 1/20 0.49
HTR3C Q8WXA8 1/20 0.49
PNMT P11086 2/20 0.49
TAAR1 Q96RJ0 3/20 0.47
TSHR P16473 1/20 0.45
RECQL P46063 1/20 0.45
SLC2A1 P11166 1/20 0.45
AOC3 Q16853 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
PLAAT3 P53816 1/20 0.42
PLAAT5 Q96KN8 1/20 0.42
PLAAT2 Q9NWW9 1/20 0.42
PLAAT4 Q9UL19 1/20 0.42
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9967760 0.83 PNMT (0.55) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6570034 0.81 TAAR1 (0.47) TAAR1NPC1IDO1
SCHEMBL6569353 0.79 TSHR (0.47) TSHRKMT2A
SCHEMBL25786628 0.77 PNMT (0.51) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5241228 0.76 TAAR1 (0.68) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5149468 0.76 TSHR (0.58) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5103603 0.75 PNMT (0.58) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL11139523 0.75 PNMT (0.50) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL11253786 0.75 PNMT (0.50) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL25769144 0.75 TSHR (0.47) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404325-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2004-04-07 EP disclosed
WO-2002096420-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2002-12-05 WO disclosed
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed